TrialBritish journal of cancer2019

A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.

Elena Elez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.